Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204561650> ?p ?o ?g. }
- W3204561650 endingPage "adv00585" @default.
- W3204561650 startingPage "adv00585" @default.
- W3204561650 abstract "Optimal management of atopic dermatitis requires a comprehensive assessment of response to treatment in order to inform therapeutic decisions. In a real-world setting, successful response to atopic dermatitis treatment is measured by sustained improvements in signs, symptoms, and quality of life. Post-hoc analyses of a 1-year, randomized, double-blinded, placebo- controlled trial (NCT02260986) of dupilumab with concomitant topical corticosteroids in 421 adults with moderate-to-severe atopic dermatitis (of whom 315/106 received placebo/dupilumab (of whom 315 received placebo and 106 received dupilumab) was performed to assess the proportion of responders to dupilumab through a multidimensional composite endpoint. At 6-months, 80.2% of dupilumab-treated vs 40.0% placebo patients (p < 0.0001) achieved improvement in signs (Eczema Area and Severity Index ≤ 7), symptoms (worst itch score ≤ 4), or quality of life (Dermatology Life Quality Index ≤5), representative of minimal/clear atopic dermatitis. All 3 endpoints, indicative of no/minimal atopic dermatitis, were achieved by 44.3% of dupilumab-treated vs 10.2% placebo patients (p < 0.0001) and sustained through 1 year. Dupilumab treatment provided sustained clinically meaningful improvement in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis." @default.
- W3204561650 created "2021-10-11" @default.
- W3204561650 creator A5000398504 @default.
- W3204561650 creator A5011739266 @default.
- W3204561650 creator A5012209760 @default.
- W3204561650 creator A5015905197 @default.
- W3204561650 creator A5050304186 @default.
- W3204561650 creator A5055081212 @default.
- W3204561650 creator A5055907875 @default.
- W3204561650 creator A5060607282 @default.
- W3204561650 creator A5069284241 @default.
- W3204561650 creator A5086116920 @default.
- W3204561650 creator A5087631945 @default.
- W3204561650 date "2021-11-10" @default.
- W3204561650 modified "2023-10-11" @default.
- W3204561650 title "Dupilumab Provides Rapid and Sustained Clinically Meaningful Responses in Adults with Moderate-to-severe Atopic Dermatitis" @default.
- W3204561650 cites W1583257755 @default.
- W3204561650 cites W2003679738 @default.
- W3204561650 cites W2031370519 @default.
- W3204561650 cites W2043469120 @default.
- W3204561650 cites W2058562555 @default.
- W3204561650 cites W2087624875 @default.
- W3204561650 cites W2096991001 @default.
- W3204561650 cites W2101401558 @default.
- W3204561650 cites W2105521580 @default.
- W3204561650 cites W2109260550 @default.
- W3204561650 cites W2200308911 @default.
- W3204561650 cites W2593244680 @default.
- W3204561650 cites W2610814011 @default.
- W3204561650 cites W2613543041 @default.
- W3204561650 cites W2744776760 @default.
- W3204561650 cites W2766462184 @default.
- W3204561650 cites W2914603675 @default.
- W3204561650 cites W2916274906 @default.
- W3204561650 cites W2965009353 @default.
- W3204561650 cites W2968987915 @default.
- W3204561650 cites W2995377367 @default.
- W3204561650 cites W3000532789 @default.
- W3204561650 cites W3016385680 @default.
- W3204561650 cites W3017596435 @default.
- W3204561650 cites W3022007005 @default.
- W3204561650 cites W3033412594 @default.
- W3204561650 cites W3036639957 @default.
- W3204561650 cites W3047057201 @default.
- W3204561650 cites W3063829097 @default.
- W3204561650 cites W3080248788 @default.
- W3204561650 cites W3086746958 @default.
- W3204561650 cites W3122709652 @default.
- W3204561650 cites W3125588754 @default.
- W3204561650 doi "https://doi.org/10.2340/actadv.v101.307" @default.
- W3204561650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34618162" @default.
- W3204561650 hasPublicationYear "2021" @default.
- W3204561650 type Work @default.
- W3204561650 sameAs 3204561650 @default.
- W3204561650 citedByCount "7" @default.
- W3204561650 countsByYear W32045616502022 @default.
- W3204561650 countsByYear W32045616502023 @default.
- W3204561650 crossrefType "journal-article" @default.
- W3204561650 hasAuthorship W3204561650A5000398504 @default.
- W3204561650 hasAuthorship W3204561650A5011739266 @default.
- W3204561650 hasAuthorship W3204561650A5012209760 @default.
- W3204561650 hasAuthorship W3204561650A5015905197 @default.
- W3204561650 hasAuthorship W3204561650A5050304186 @default.
- W3204561650 hasAuthorship W3204561650A5055081212 @default.
- W3204561650 hasAuthorship W3204561650A5055907875 @default.
- W3204561650 hasAuthorship W3204561650A5060607282 @default.
- W3204561650 hasAuthorship W3204561650A5069284241 @default.
- W3204561650 hasAuthorship W3204561650A5086116920 @default.
- W3204561650 hasAuthorship W3204561650A5087631945 @default.
- W3204561650 hasBestOaLocation W32045616501 @default.
- W3204561650 hasConcept C126322002 @default.
- W3204561650 hasConcept C142724271 @default.
- W3204561650 hasConcept C159110408 @default.
- W3204561650 hasConcept C16005928 @default.
- W3204561650 hasConcept C168563851 @default.
- W3204561650 hasConcept C203092338 @default.
- W3204561650 hasConcept C204787440 @default.
- W3204561650 hasConcept C27081682 @default.
- W3204561650 hasConcept C2776173921 @default.
- W3204561650 hasConcept C2778329239 @default.
- W3204561650 hasConcept C2779384505 @default.
- W3204561650 hasConcept C2779824493 @default.
- W3204561650 hasConcept C2779951463 @default.
- W3204561650 hasConcept C2780564577 @default.
- W3204561650 hasConcept C2780699399 @default.
- W3204561650 hasConcept C30036603 @default.
- W3204561650 hasConcept C71924100 @default.
- W3204561650 hasConceptScore W3204561650C126322002 @default.
- W3204561650 hasConceptScore W3204561650C142724271 @default.
- W3204561650 hasConceptScore W3204561650C159110408 @default.
- W3204561650 hasConceptScore W3204561650C16005928 @default.
- W3204561650 hasConceptScore W3204561650C168563851 @default.
- W3204561650 hasConceptScore W3204561650C203092338 @default.
- W3204561650 hasConceptScore W3204561650C204787440 @default.
- W3204561650 hasConceptScore W3204561650C27081682 @default.
- W3204561650 hasConceptScore W3204561650C2776173921 @default.
- W3204561650 hasConceptScore W3204561650C2778329239 @default.
- W3204561650 hasConceptScore W3204561650C2779384505 @default.